<< Back
Price to Revenue (TTM)
This is the current Price divided by the Sales Per Share for the trailing twelve months. If there is a preliminary earnings announcement for an interim period that has recently ended, the revenue (sales) values from this announcement will be used in calculating the trailing twelve month revenue per share.
NASDAQ (US Dollar)
$67.63
 Stock is Down 0.39 (0.57%)
Data as of 05/21/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at the Bank of America Merrill Lynch Healthcare Conference

May 16, 2018 9:20 a.m. PT
Play
2018 Annual Meeting of Stockholders

May 09, 2018 10:00 a.m. PT
Play
First Quarter 2018 Gilead Sciences Earnings Conference Call

May 01, 2018 1:30 p.m. PT
Play
Gilead Sciences at the RBC Capital Markets 2018 Global Healthcare Conference

February 21, 2018 9:00 a.m. ET
Play